Sánchez-Martínez María Lourdes, Aguilar-Caballos María Paz, Gómez-Hens Agustina
Department of Analytical Chemistry, University of Córdoba, Campus of Rabanales, Marie-Curie Annex building, 14071-Córdoba, Spain.
Anal Chem. 2007 Oct 1;79(19):7424-30. doi: 10.1021/ac070761l. Epub 2007 Sep 5.
The versatility of the fluorescence polarization immunoassay (FPIA) is increased by using two long-wavelength labels, Nile Blue and a ruthenium(II) chelate. The first label has been used to study the potential of FPIA on a solid surface using dry reagent technology. The aminoglycoside antibiotic amikacin has been used as an analyte model, and the method has been applied to the analysis of serum samples. The second label has been used to show the practical application of FPIA to the determination of macromolecules, using gliadins as an analyte model, which have been determined in gluten-free food. Very low amounts of anti-amikacin antibodies and amikacin-Nile Blue tracer were immobilized onto nitrocellulose membranes, for the development of the amikacin method, and the consumption of reagents is lower than in conventional FPIA. Only the addition of the standard or sample extract at an adequate pH is required at the analysis time. The analyte displaces the tracer from the tracer-antibody immunocomplex, obtaining a decrease in the fluorescence polarization proportional to the analyte concentration. The gliadin-Ru(II) chelate tracer shows a relatively long lifetime, which allows the observation of differences in fluorescence polarization values between the tracer-antibody complex and the tracer alone. The dynamic range of the calibration graphs for both analytes is 0.5-10 microg mL-1 and the detection limits are 0.1 and 0.09 microg mL-1 for amikacin and gliadins, respectively. The study of the precision gave values of relative standard deviations lower than 5 and 1.5% for the amikacin and gliadin methods, respectively. Amikacin was determined in human serum samples using a previous deproteinization step with acetonitrile, obtaining recovery values in the range 83.4-122.8%. The gliadin method was applied to the analysis of gluten-free food samples by using a previous extraction step. The recovery study gave values between 94.3 and 105.0%.
通过使用两种长波长标记物尼罗蓝和钌(II)螯合物,荧光偏振免疫分析(FPIA)的通用性得到了提高。第一种标记物已被用于利用干试剂技术研究FPIA在固体表面的潜力。氨基糖苷类抗生素阿米卡星被用作分析物模型,该方法已应用于血清样本的分析。第二种标记物已被用于展示FPIA在大分子测定中的实际应用,以麦醇溶蛋白作为分析物模型,已在无麸质食品中对其进行了测定。将极少量的抗阿米卡星抗体和阿米卡星 - 尼罗蓝示踪剂固定在硝酸纤维素膜上,用于开发阿米卡星检测方法,该方法的试剂消耗量低于传统FPIA。在分析时仅需在适当的pH值下加入标准品或样品提取物。分析物将示踪剂从示踪剂 - 抗体免疫复合物中置换出来,导致荧光偏振降低,其降低程度与分析物浓度成正比。麦醇溶蛋白 - 钌(II)螯合物示踪剂具有相对较长的寿命,这使得能够观察到示踪剂 - 抗体复合物与单独示踪剂之间荧光偏振值的差异。两种分析物校准曲线的动态范围均为0.5 - 10 μg mL-1,阿米卡星和麦醇溶蛋白的检测限分别为0.1和0.09 μg mL-1。精密度研究表明,阿米卡星和麦醇溶蛋白检测方法的相对标准偏差值分别低于5%和1.5%。使用先前用乙腈进行脱蛋白步骤的方法对人血清样本中的阿米卡星进行了测定,回收率在83.4 - 122.8%范围内。麦醇溶蛋白检测方法通过先前的提取步骤应用于无麸质食品样本的分析。回收率研究得到的值在94.3%至105.0%之间。